[1] |
Hajjar ER,Cafiero AC,Hanlon JT. Polypharmacy in elderly patients[J]. Am J Geriat Pharmacother, 2007, 5(4):345-351.
|
[2] |
Shah BM,Hajjar ER.Polypharmacy, adverse drug reactions, and geriatric syndromes[J]. Clin Geriatr Med, 2012, 28(2):173-186.
|
[3] |
Sergi G,De Rui M,Sarti S, et al. Polypharmacy in the elderly: can comprehensive geriatric assessment reduce inappropriate medication use[J]? Drugs Aging, 2011, 28(7):509-518.
|
[4] |
Schmader KE,Hanlon JT,Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly[J].Am J Med, 2004, 116(6):394-401.
|
[5] |
王秋梅,刘晓红.老年人综合评估的实施[J].中华老年医学杂志,2012,31(1):13-15.
|
[6] |
Scott IA,Hilmer SN,Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing[J]. JAMA Intern Med, 2015, 175(5):827-834.
|
[7] |
杜望春,杨涛,高宁舟,等.老年人药品不良反应的监测和预防[J].药物流行病学杂志,2014,23(6):385-388.
|
[8] |
Gokula M,Holmes HM. Tools to reduce polypharmacy[J]. Clin Geriatr Med, 2012, 28(2):323-341.
|
[9] |
袁玉辉,张波,梅丹.老年人药物相关问题和用药管理[J].中国药学杂志,2011,46(12):966-968.
|
[10] |
Fischer MA,Stedman MR,Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions[J]. J Gen Intern Med, 2010, 25(4):284-290.
|
[11] |
Stegemann S,Ecker F,Maio M, et al. Geriatric drug therapy: neglecting the inevitable majority[J]. Ageing Res Rev, 2010, 9(4):384-398.
|
[12] |
Reeve E,Shakib S,Hendrix I, et al. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process[J]. Br J Clin Pharmacol, 2014, 78(4):738-747.
|
[13] |
曾平,闫雪莲,朱鸣雷,等.老年人药物重整的应用效果分析[J].中华老年多器官疾病杂志,2016,15(8):575-578.
|